BE788516A
(fr)
|
1971-09-10 |
1973-03-07 |
Lonza Ag |
Procede de fabrication d'esters alcoxyacetylacetiques
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
DE2658401A1
(de)
|
1976-12-23 |
1978-07-06 |
Merck Patent Gmbh |
Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
US4575694A
(en)
|
1984-03-05 |
1986-03-11 |
Allied Corporation |
Coaxial connector
|
DE3900735A1
(de)
|
1989-01-12 |
1990-07-26 |
Hoechst Ag |
Neue mehrfunktionelle (alpha)-diazo-(beta)-ketoester, verfahren zu ihrer herstellung und deren verwendung
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
US6703396B1
(en)
|
1990-02-01 |
2004-03-09 |
Emory University |
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
|
US5914331A
(en)
|
1990-02-01 |
1999-06-22 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
DE4014649A1
(de)
|
1990-05-08 |
1991-11-14 |
Hoechst Ag |
Neue mehrfunktionelle verbindungen mit (alpha)-diazo-ss-ketoester- und sulfonsaeureester-einheiten, verfahren zu ihrer herstellung und deren verwendung
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
SE9702772D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
AU1403099A
(en)
|
1997-11-14 |
1999-06-07 |
Merck & Co., Inc. |
Alpha-1a adrenergic receptor antagonists
|
EP1178969B1
(en)
|
1998-11-09 |
2005-07-13 |
James Black Foundation Limited |
Gastrin and cholecystokinin receptor ligands
|
GB2345058A
(en)
|
1998-12-01 |
2000-06-28 |
Cerebrus Pharm Ltd |
Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system
|
AP2001002169A0
(en)
|
1998-12-25 |
2001-06-30 |
Shionogi & Co |
Aromatic heterocycle compounds having hiv intergrase inhibiting activities
|
AU2001262732A1
(en)
|
2000-06-14 |
2001-12-24 |
Shionogi And Co., Ltd. |
Inhibitor for enzyme having two divalent metal ions as active centers
|
ES2587564T1
(es)
|
2001-08-10 |
2016-10-25 |
Shionogi & Co., Ltd. |
Agente antiviral
|
PL370355A1
(en)
|
2001-10-03 |
2005-05-16 |
Ucb, S.A. |
Pyrrolidinone derivatives
|
NZ533057A
(en)
|
2001-10-26 |
2005-11-25 |
Angeletti P Ist Richerche Bio |
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
|
WO2003042176A1
(fr)
|
2001-11-13 |
2003-05-22 |
Shiseido Co., Ltd. |
Compose azabicyclo, inhibiteur de metalloprotease matricielle et preparation cutanee
|
AU2003248872A1
(en)
|
2002-07-09 |
2004-01-23 |
Bristol-Myers Squibb Company |
Hiv integrase inhibitors
|
US7517532B2
(en)
|
2002-09-11 |
2009-04-14 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
|
EP1564210B9
(en)
|
2002-11-20 |
2010-03-31 |
Japan Tobacco Inc. |
4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
|
PT1583542E
(pt)
|
2003-01-14 |
2008-09-17 |
Gilead Sciences Inc |
Composições e métodos para terapia de combinação antiviral
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
CA2554120A1
(en)
|
2004-01-30 |
2005-08-18 |
Merck & Co., Inc. |
N-benzyl-3,4-dihydroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integras inhibitors
|
WO2005086700A2
(en)
|
2004-03-09 |
2005-09-22 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
WO2006028523A2
(en)
|
2004-04-29 |
2006-03-16 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
US7538112B2
(en)
|
2004-05-07 |
2009-05-26 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
US7273859B2
(en)
|
2004-05-12 |
2007-09-25 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors: cyclic pyrimidinone compounds
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
US7531554B2
(en)
|
2004-05-20 |
2009-05-12 |
Japan Tobacco Inc. |
4-oxoquinoline compound and use thereof as HIV integrase inhibitor
|
EP2332538A1
(en)
|
2004-05-21 |
2011-06-15 |
Japan Tobacco, Inc. |
Combinations comprising a 4-isoquinolone derivative and anti-HIV agents
|
EP1790638B1
(en)
|
2004-09-15 |
2013-04-03 |
Shionogi Co., Ltd. |
Carbamoylpyridone derivative having hiv integrase inhibitory activity
|
EP1973906A1
(en)
|
2004-12-23 |
2008-10-01 |
Virochem Pharma Inc. |
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
EP1852434B1
(en)
|
2005-02-21 |
2011-07-13 |
Shionogi Co., Ltd. |
Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
|
EP3372281B1
(en)
|
2005-04-28 |
2021-07-07 |
VIIV Healthcare Company |
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
|
AR057023A1
(es)
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
|
AU2006272521A1
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of HIV
|
ES2569357T3
(es)
|
2005-10-27 |
2016-05-10 |
Shionogi & Co., Ltd. |
Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora sobre integrasa de HIV
|
WO2007079260A1
(en)
|
2005-12-30 |
2007-07-12 |
Gilead Sciences, Inc. |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
US7601844B2
(en)
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
EP1978960A4
(en)
|
2006-02-01 |
2009-12-02 |
Japan Tobacco Inc |
USE OF 6- (3-CHLORO-2-FLUORBENZYL) -1 - [(2S) -1-HYDROXY-3-METHYLBUTAN-2-YL [-7-METHOXY-4-OXO-1,4-DIHYDROCHINOLINE-3- CARBOXYLIC ACID OR SALT THEREOF FOR THE TREATMENT OF RETROVIRUS INFECTION
|
BRPI0708685B8
(pt)
|
2006-03-06 |
2021-05-25 |
Japan Tobacco Inc |
composto de 4-oxoquinolina, seu uso e método para produção dos mesmos
|
CN101437801B
(zh)
|
2006-03-06 |
2013-02-06 |
日本烟草产业株式会社 |
制备4-氧代喹啉化合物的方法
|
US7893055B2
(en)
|
2006-06-28 |
2011-02-22 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
CA2657034A1
(en)
|
2006-07-19 |
2008-01-24 |
University Of Georgia Research Foundation, Inc. |
Pyridinone diketo acids: inhibitors of hiv replication in combination therapy
|
AU2007293774C1
(en)
|
2006-09-07 |
2014-12-18 |
Albert Einstein College Of Medicine, Inc. |
Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
|
EP2644587A3
(en)
|
2006-09-12 |
2013-10-23 |
Gilead Sciences, Inc. |
Process and intermediates for preparing integrase inhibitors
|
EP2084160A1
(en)
|
2006-10-18 |
2009-08-05 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
AP2986A
(en)
|
2007-02-23 |
2014-09-30 |
Gilead Sciences Inc |
Modulators of pharmacokinetic properties of therapeutics
|
US20080280945A1
(en)
|
2007-05-09 |
2008-11-13 |
Sachin Lohani |
Crystalline forms of an HIV integrase inhibitor
|
BRPI0813955A2
(pt)
|
2007-06-29 |
2017-05-09 |
Gilead Sciences Inc |
composições terapêuticas e o uso das mesmas
|
AP2965A
(en)
|
2007-06-29 |
2014-09-30 |
Gilead Sciences Inc |
Therapeutic compositions and the use thereof
|
WO2009018350A1
(en)
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Pyrone analog compositions and methods
|
AR068403A1
(es)
|
2007-09-11 |
2009-11-18 |
Gilead Sciences Inc |
Proceso e intermediarios para la preparacion de inhibidores de integrasa
|
EP2220046B1
(en)
|
2007-11-16 |
2014-06-18 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
GB0803019D0
(en)
|
2008-02-19 |
2008-03-26 |
Btg Int Ltd |
Fluorinated compounds
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
US20100272811A1
(en)
|
2008-07-23 |
2010-10-28 |
Alkermes,Inc. |
Complex of trospium and pharmaceutical compositions thereof
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
SI2320908T1
(sl)
|
2008-07-25 |
2014-05-30 |
Viiv Healthcare Company |
Predzdravila dolutegravirja
|
WO2010011816A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP2320909B8
(en)
|
2008-07-25 |
2016-03-30 |
VIIV Healthcare Company |
Chemical compounds
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
MX351942B
(es)
|
2008-12-11 |
2017-11-03 |
Shionogi & Co |
Sintesis de inhibidores de integrasa de vih de carbamoil-piridona e intermediarios.
|
KR101678563B1
(ko)
|
2008-12-11 |
2016-11-22 |
비이브 헬쓰케어 컴퍼니 |
카르바모일피리돈 hiv 인테그라제 억제제를 위한 제조방법 및 중간체
|
WO2010110231A1
(ja)
|
2009-03-26 |
2010-09-30 |
塩野義製薬株式会社 |
置換された3-ヒドロキシ-4-ピリドン誘導体
|
TWI518084B
(zh)
|
2009-03-26 |
2016-01-21 |
鹽野義製藥股份有限公司 |
哌喃酮與吡啶酮衍生物之製造方法
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
CN102803260B
(zh)
|
2009-06-15 |
2016-02-10 |
盐野义制药株式会社 |
被取代的多环性氨基甲酰基吡啶酮衍生物
|
US8637674B2
(en)
|
2009-09-02 |
2014-01-28 |
Ewha University-Industry Collaboration Foundation |
Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
|
PE20160180A1
(es)
|
2010-01-27 |
2016-05-04 |
Viiv Healthcare Co |
Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos.
|
WO2011105590A1
(ja)
|
2010-02-26 |
2011-09-01 |
日本たばこ産業株式会社 |
1,3,4,8-テトラヒドロ-2H-ピリド[1,2-a]ピラジン誘導体及びそのHIVインテグラーゼ阻害剤としての利用
|
TWI582097B
(zh)
|
2010-03-23 |
2017-05-11 |
Viiv醫療保健公司 |
製備胺甲醯吡啶酮衍生物及中間體之方法
|
US20130165489A1
(en)
|
2010-05-03 |
2013-06-27 |
The Trustees Of The University Of Pennsylvania |
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
|
EA201291301A1
(ru)
|
2010-07-02 |
2013-05-30 |
Джилид Сайэнс, Инк. |
Производные 2-хинолинилуксусной кислоты в качестве противовирусных соединений против вич
|
AP2013006706A0
(en)
|
2010-07-02 |
2013-02-28 |
Gilead Sciences Inc |
Napht-2-ylacetic acid derivatives to treat AIDS
|
US20130210809A1
(en)
|
2010-07-14 |
2013-08-15 |
Christelle Boléa |
Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
ES2710609T3
(es)
|
2010-08-05 |
2019-04-26 |
Shionogi & Co |
Procedimiento de preparación de un compuesto que tiene actividad inhibidora de la integrasa del HIV
|
HUE039859T2
(hu)
|
2010-09-24 |
2019-02-28 |
Shionogi & Co |
Helyettesített policiklusos karbamoil-piridon-származék prodrug
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
EA024952B1
(ru)
|
2011-04-21 |
2016-11-30 |
Джилид Сайэнс, Инк. |
Бензотиазолы и их применение для лечения вич-инфекции
|
US20140213553A1
(en)
|
2011-05-03 |
2014-07-31 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
US9328075B2
(en)
|
2011-05-05 |
2016-05-03 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for treating influenza
|
CA2840095A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
US9206197B2
(en)
|
2011-09-14 |
2015-12-08 |
Mapi Pharma Ltd. |
Amorphous form of dolutegravir
|
US9200009B2
(en)
|
2011-10-12 |
2015-12-01 |
Shionogi & Co., Ltd. |
Polycyclic pyridone derivative having integrase inhibitory activity
|
CN104114559B
(zh)
|
2011-12-12 |
2016-08-24 |
拜耳知识产权有限责任公司 |
氨基取代的咪唑并哒嗪
|
RU2014115227A
(ru)
|
2012-04-20 |
2015-10-27 |
Джилид Сайэнс, Инк. |
Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
WO2014014933A1
(en)
|
2012-07-20 |
2014-01-23 |
Merck Sharp & Dohme Corp. |
Hiv treatment with amido-substituted pyrimidinone derivatives
|
EP2877469A4
(en)
|
2012-07-25 |
2016-04-06 |
Merck Sharp & Dohme |
SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS INHIBITORS OF HIV INTEGRASE
|
SG11201500812QA
(en)
|
2012-08-03 |
2015-04-29 |
Gilead Sciences Inc |
Process and intermediates for preparing integrase inhibitors
|
ES2615302T3
(es)
|
2012-11-08 |
2017-06-06 |
Bristol-Myers Squibb Company |
Compuestos de piridilo sustituidos con heteroarilo útiles como modulares de cinasa
|
CN104902905A
(zh)
|
2012-12-14 |
2015-09-09 |
葛兰素史克有限责任公司 |
药物组合物
|
EP2931730B1
(en)
*
|
2012-12-17 |
2019-08-07 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
US20160000721A1
(en)
|
2012-12-21 |
2016-01-07 |
Merck Sharp & Dohme Corp. |
Gastro-retentive formulations
|
UA114351C2
(uk)
|
2012-12-21 |
2017-05-25 |
Гіліад Сайєнсіз, Інк. |
Поліциклічні карбамоїлпіридонові сполуки та їх фармацевтичне застосування
|
US20140221355A1
(en)
|
2012-12-21 |
2014-08-07 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
US20140221380A1
(en)
|
2012-12-27 |
2014-08-07 |
Japan Tobacco Inc. |
SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
|
WO2014200880A1
(en)
|
2013-06-13 |
2014-12-18 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
|
NO2865735T3
(zh)
*
|
2013-07-12 |
2018-07-21 |
|
|
PL3019503T3
(pl)
*
|
2013-07-12 |
2018-01-31 |
Gilead Sciences Inc |
Policykliczne związki karbamoilopirydonowe i ich zastosowanie do leczenia infekcji hiv
|
WO2015039348A1
(en)
*
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
MX367057B
(es)
|
2013-09-27 |
2019-08-02 |
Merck Sharp & Dohme |
Derivados de quinolizina sustituidos utiles como inhibidores de integrasa del vih.
|
US20150146340A1
(en)
|
2013-11-26 |
2015-05-28 |
Qualcomm Incorporated |
Multilayer ceramic capacitor including at least one slot
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
US9856271B2
(en)
|
2014-01-21 |
2018-01-02 |
Laurus Labs Limited |
Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
|